0       0

2019 AABB Annual Meeting


SN5-33 - SN5-33: Research and Progress (RAP) Session: A Whole New World: If Whole Blood is the “New” Transfusion Therapy, then How Do We Manage WB Inventories?


Oct 20, 2019 4:00pm ‐ Oct 20, 2019 5:30pm

Description

This RAP session will challenge the participants to evaluate the impact of Whole Blood on our professional and local communities. The practical implementation of supply and demand will be presented along with a comparison of patient safety and product attributes, and practical management of a whole blood inventory. Army Col. Dr. Andrew Cap will discuss optimization of whole blood collection and storage in a military setting, including the impact of universal low-titer, group O Whole Blood (LTOWB) on battlefield resuscitation practices. Dr. David Mair will present his experiences with providing whole blood versus component therapy for civilian trauma, especially the challenges of maintaining a dual inventory as a large scale blood supplier. As the director of a centralized transfusion service, Dr. Darrell Triulzi will also compare and contrast the transfusion service and collection center perspectives on whole blood inventory management. Dr. Triulzi will also summarize the data comparing clinical outcomes and in vivo hemostatic function of platelets from cold-stored whole blood against that of standard platelet concentrates. Following the formal presentations, the audience will be asked to engage in an interactive discussion regarding the logistics of implementing whole blood programs, the risks and benefits of whole blood resuscitation for trauma victims, and the long term impact of the paradigm shift away from traditional component therapy.

Learning Objectives:
  • Discuss transfusion service benefits and challenges for implementation and inventory management of Whole Blood (WB).
  • Discuss collection center perspectives surrounding donor collections of WB and resource allocation when maintaining a dual inventory (WB versus components).
  • Compare practical and clinical aspects of implementation of the use of WB for safety, efficacy and cost effectiveness.
  • Describe the concerns related to platelet hemostatic function in light of the cold storage of WB and describe the concerns for returned WB units.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content